Niaspan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2016
0519962016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND AND OBJECTIVE We investigated axonal plasticity in the bilateral motor cortices and the long term therapeutic effect… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
We investigated the changes and the molecular mechanisms of cerebral vascular damage and tested the therapeutic effects of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
INTRODUCTION Niaspan, an extended-release formulation of Niacin (vitamin B3), has been widely used to increase high density… (More)
Is this relevant?
2007
2007
OBJECTIVE High-density lipoprotein (HDL) is implicated in the modulation of angiogenesis. In this study, we investigated whether… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Diabetic dyslipidemia is characterized by high triglyceride levels; low high-density lipoprotein cholesterol levels… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Crystalline nicotinic acid (immediate-release niacin) is effective therapy for lipoprotein regulation and cardiovascular risk… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
This study compared the efficacy and safety of a once-a-night, time-release niacin formulation, Niaspan (Kos Pharmaceuticals… (More)
Is this relevant?
1998
1998
Immediate-release niacin manifests beneficial effects in cardiovascular disease with respect to dyslipidemic states. It lowers… (More)
Is this relevant?
1998
1998
Niacin is a useful lipid-modifying drug because it (1) decreases low-density lipoprotein (LDL) cholesterol, total cholesterol… (More)
Is this relevant?
1996
1996
BACKGROUND: The present study was designed to determine the efficacy and safety of Niaspan (Kos Pharmaceuticals, Inc, Hollywood… (More)
Is this relevant?